Team:Imperial College London/M2/EncapsulationRationale
From 2009.igem.org
JamesField (Talk | contribs) (→Encapsulation Rationale) |
(→Encapsulation Rationale) |
||
Line 45: | Line 45: | ||
</tr></table></html> | </tr></table></html> | ||
<br> | <br> | ||
+ | |||
+ | <html><center><a href="https://2009.igem.org/Team:Imperial_College_London/M1#Module2_Contents"><img width=150px src="https://static.igem.org/mediawiki/2009/1/10/II09_TourArrow.png"></a> | ||
+ | </html> | ||
{{Imperial/09/TemplateBottom}} | {{Imperial/09/TemplateBottom}} |
Revision as of 12:40, 9 October 2009
Module 2 - Encapsulsation Overview
Encapsulation Rationale
In nature, encapsulation pathways such as spore formation, aliginate biosynthesis and colanic acid production all share one common feature: they require a large number of genes. For this reason, we decided that the best way encapsulate our chassis was via the modulation of an existing pathway.
E.coli naturally produces a harmless acid resistant polymer known as colanic acid. Colanic acid is a polymer of glucose, galactose and glucuronic acid. By tapping into the pathway that initiates colanic acid biosynthesis, we can turn on its production via the modulation of a gene called RcsB.
In nature, colanic acid acts as a binding agent between individual cells over which a biofilm can be formed. While colanic acid itself is harmless, biofilm formation is associated with the production of a number of virulence factors. To prevent biofilm formation from occuring, we have tapped into a second pathway such that our cells become locked into colanic acid production. The gene responsible for preventing biofilm formation is a transcription factor called YgiV.
In nature, colanic acid is associated with but not attached to the cell surface. To facilitate whole cell encapsulation, we have modified a third pathway to fix the colanic acid to the surface of the cell. This involves an enzyme called Rfal.